Letters of Concern

The pathogenesis of potential myocarditis induced by COVID-19 vaccine (12 November 2021, The American Journal of Emergency Medicine, Kounis et al Department of Cardiology, University of Patras Medical School, Patras, Greece)

COVID-19 Vaccination with Special Reference to Adenoviral Vectors, Clotting Disorders and Old Age , (November 2021, Journal of Geriatrics and Palliative Care, Jargin SV, Department of Pathology, People’s Friendship University of Russia, Russian Federation)

Time to consider neuroinfammation as a booster efect of cerebral venous sinus thrombosis in vaccine‑induced immune thrombotic thrombocytopenia? (Marchandot et al, Division of Cardiovascular Medicine, Nouvel Hôpital, France, 26 September 2021, Journal of Thrombosis and Thrombolysis)

Covid-19 vaccines: In the rush for regulatory approval, do we need more data? (13 September 2021, BMJ, Rebecca J. van der Post)

Understanding risk of thrombosis with thrombocytopenia syndrome after Ad26.COV2.S vaccination (28 August 2021, Frontiers of Medicine, Prathit A. Kulkarni, Vinay Prasad – Infectious Diseases, Baylor College of Medicine, Houston; Department of Epidemiology and Biostatistics, University of California-San Francisco)

Myocarditis followed by CoViD-19 vaccines: A cause for concern or a reversible minor effect? (14 June 2021, BMJ, Hamid Merchant, Subject Leader in Pharmacy, University of Huddersfield, United Kingdom)

Do doctors have to have the covid-19 vaccine? (29 March 2021, BMJ)

Will we ever know the true harms and benefits of Covid-19 vaccines? (26 May 2021, BMJ, Allan S. Cunningham, Retired pediatrician, Cooperstown NY, USA)

In the rush for regulatory approval, do we need more data? (18 May 2021, BMJ, Peter Doshi)

In the rush for regulatory approval, do we need more data? (18 May 2021, BMJ, Bernadette Pajer, Public Policy Director, Informed Choice WA, Washington State, USA)

COVID vaccines and thrombotic events: is mRNA translation and spike protein synthesis by platelets a real possibility? (20 March 2021, BMJ, Hamid Merchant, Leader in Pharmacy, University of Huddersfield, UK, Queensgate)

WHO says rollout of AstraZeneca vaccine should continue, as Europe divides over safety (16 March 2021, BMJ)